- Nachrichtendetail
-
28.06.2024 13:11:47 - dpa-AFX: *REGENERON: ODRONEXTAMAB RECOMMENDED FOR EU APPROVAL BY CHMP TO TREAT R/R FOLLICULAR LYMPHOMA AND DLBCL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.094,575 | 16.07.24 21:20:38 | +12,465 | +1,15% | 1.093,820 | 1.095,780 | 1.097,290 | 1.082,110 |
